ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PSNL vs MRK // REVENUE GROWTH (YOY)

Personalis Inc. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: PSNL 1 — MRK 10
▲ REVENUE GROWTH (YOY) LEADER: MRK
revenue-growth
-17.70%
revenue-growth
1.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PSNL VS. MRK) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PSNL MRK SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 22.70% 74.80% -52.10 MRK /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 20.70% -55.70 MRK /roic <GO>
EV/EBITDA & P/E Valuation — 15.3x — TIE /valuation <GO>
Free Cash Flow Yield -4.67% 3.42% -8.09 MRK /fcf-yield <GO>
Operating Margin -60.00% 34.30% -94.30 MRK /operating-margins <GO>
Net Profit Margin -60.00% 28.10% -88.10 MRK /net-margins <GO>
Revenue Growth (YoY) ACTIVE -17.70% 1.30% -19.00 MRK /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.26% -2.26 MRK /dividend-safety <GO>
Altman Z-Score & Debt/Equity 11.50 5.19 +6.31 PSNL /balance-sheet <GO>
Piotroski F-Score Quality 3/9 7/9 -4.00 MRK /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 49.0 51.7 -2.70 MRK /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.92 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 18.4x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.70B $361.02B -$359.32B MRK /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PSNL REV MRK REV PSNL GROSS % MRK GROSS % PSNL FCF MRK FCF
FY 2025 $69.6M $65.01B 22.7% 74.8% -$79.5M $12.36B
FY 2024 $84.6M $64.17B 31.7% 76.3% -$46.8M $18.10B
FY 2023 $73.5M $60.12B — — -$56.3M $10.30B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PSNL // BETA —
MRK // BETA 0.92